Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Duncan Gallagher is Director at Health Catalyst. OQRO lists 4 transactions filed with the SEC under this name, the latest on Feb 20, 2026, each linked to the official Form 4.
Director
Disclosures on record
4
Companies involved
1
As of the latest filing on , Duncan Gallagher reported holding 132,023 shares of Health Catalyst (HCAT), worth about $199K at the last close of $2 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Health Catalyst HCAT | 132,023 | 132K direct | $2 | $199K | Feb 17, 2026 |
Is this Duncan Gallagher’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Health CatalystHCAT
4 disclosures · Dec 2024 – Feb 2026 · 2 sold
Feb 17, 20267,562disclosed Feb 20
DetailsOfficial recordDec 1, 20256,209disclosed Dec 4
DetailsOfficial recordDec 30, 2024Sold~$31Kdisclosed Jan 2
DetailsOfficial recordDec 23, 2024Sold~$31Kdisclosed Dec 27
DetailsOfficial recordDuncan Gallagher bought shares on the open market in 2022, and has not bought since 2022. Sales in 1 of the 5 years since 2022.
Duncan Gallagher reported 2 open-market purchases and 2 sales since 2022; purchases in 2022.
| Year | Bought | Sold |
|---|---|---|
| 2024 | — | $63K2×2 trades |
| 2022 | $175K2×2 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Duncan Gallagher reported 2 open-market purchases and 2 sales here, 2022 to 2024.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Feb 17, 2026, Duncan Gallagher reported holding 132,023 shares of Health Catalyst (HCAT). At the last close of $2 on Nov 13, 2026, that is about $199K. This is the stake disclosed in filings, not a net worth.
Duncan Gallagher bought shares on the open market in 2022, and has not bought since 2022. Sales in 1 of the 5 years since 2022.
In SEC filings since 2022: the latest open-market purchase is from 2022; the latest open-market sale is from 2024.
Health Catalyst (HCAT), from 2022 to 2024: 2 purchases and 2 sales.
